Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience

被引：0
|
作者：
Sbragia, E. [1 ]
Olobardi, D. [2 ,3 ,4 ]
Novi, G. [5 ]
Lapucci, C. [1 ]
Cellerino, M. [1 ]
Boffa, G. [1 ]
Laroni, A. [1 ]
Mikulska, M. [6 ,7 ]
Sticchi, L.
Inglese, M. [1 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
[2] Osped Policlin San Martino IRCCS, Hyg Unit, Genoa, Italy
[3] Osped Policlin San Martino IRCCS, Dept Hlth Sci DiSSal, Genoa, Italy
[4] Univ Genoa, Genoa, Italy
[5] IRCCS Osped Policlin San Martino, Dept Neurol, Genoa, Italy
[6] Univ Genoa, Div Infect Dis, Genoa, Italy
[7] Osped Policlin San Martino, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-643
引用
收藏
页码：788 / 788
页数：1
相关论文
共 50 条
  • [1] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
    Sbragia, E.
    Olobardi, D.
    Giovanni, N.
    Lapucci, C.
    Boffa, G.
    Capello, E.
    Cellerino, M.
    Laroni, A.
    Sticchi, L.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 648 - 649
  • [2] Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
    Sbragia, Elvira
    Olobardi, Dario
    Novi, Giovanni
    Lapucci, Caterina
    Cellerino, Maria
    Boffa, Giacomo
    Laroni, Alice
    Mikulska, Malgorzata
    Sticchi, Laura
    Inglese, Matilde
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [3] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, M.
    Boffa, G.
    Lapucci, C.
    Sbragia, E.
    Bruschi, N.
    Mancuso, E.
    Tazza, F.
    Poire, I.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Novi, G.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 295 - 295
  • [4] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Sbragia, Elvira
    Bruschi, Nicolo
    Mancuso, Elisabetta
    Tazza, Francesco
    Poire, Ilaria
    Laroni, Alice
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    NEUROLOGY, 2021, 96 (15)
  • [5] Ocrelizumab treatment in patients with relapsing-remitting multiple sclerosis: a single-center real-world experience
    Lapucci, C.
    Boffa, G.
    Cellerino, M.
    Novi, G.
    Sbragia, E.
    Bruschi, N.
    Mancuso, E.
    Tazza, F.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 177 - 178
  • [6] Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients
    Prockl, Victoria
    Nickel, Florian T.
    Utz, Kathrin S.
    Froehlich, Kilian
    Engelhorn, Tobias
    Hilz, Max-Josef
    Lee, De-Hyung
    Linker, Ralf A.
    Huhn, Konstantin
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 415
  • [7] Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience
    Qian, Xifeng
    Chen, Heng
    Xia, Jun
    Wang, Jing
    Zhou, Xin
    Guo, Hongfeng
    MEDICAL SCIENCE MONITOR, 2018, 24 : 5887 - 5893
  • [8] Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
    Nasello, Martina
    Zancan, Valeria
    Rinaldi, Virginia
    Marrone, Antonio
    Renie, Roberta
    Diamant, Selene
    Marconi, Martina
    Le Mura, Lorenzo
    Salvetti, Marco
    Buscarinu, Maria Chiara
    Bellucci, Gianmarco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [9] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Marwan Sheikh-Taha
    American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
  • [10] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Sheikh-Taha, Marwan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 59 - 64
12345